IBS - Beyond The Bowel: The Meaning of Co-Existing Medical Problems
IBS - Beyond The Bowel: The Meaning of Co-Existing Medical Problems
IBS - Beyond The Bowel: The Meaning of Co-Existing Medical Problems
Irritable bowel syndrome (IBS) is a disorder that is defined by a specific pattern of gastrointestinal
(GI) symptoms in the absence of abnormal physical findings. The latest diagnostic criteria for IBS --
the Rome II criteria created by an international team of experts -- require that the patient have
abdominal pain for at least 12 weeks within the past 12 months and that the pain meets two of the
following three criteria: it is relieved after bowel movement, associated with change in stool
frequency, or associated with stool form. It is becoming clear, however, that these bowel symptoms
do not tell the whole story of symptoms experienced by IBS patients. People with this disorder
often have many uncomfortable non-gastrointestinal (non-GI) symptoms and other health problems
in addition to their intestinal troubles.
1. A common physical cause? One explanation for the high rates of co-existing symptoms and
conditions in IBS patients would be that there is something biologically wrong in IBS patients that
also cause other symptoms or conditions. There are a number of distinct physiological
characteristics or "abnormalities" seen in many IBS patients, although none of them are found in all
IBS patients. These include: heightened pain sensitivity in the gut, increased intestinal contractions
(motility) or hyper-reactivity in response to meals or stress (too much movement of the intestines -
this is the reason why IBS was called spastic colon in the past), patterns of dysfunction in the
autonomic nervous system (that part of the nervous system that helps regulate our inner body
functions), and vague signs of immune activation seen in some IBS patients. Although one could
suggest ways in which these physiological abnormalities would play a role in some other disorders
that co-exist with IBS, there is little evidence so far of a common pattern of physical abnormality
that could link IBS and its most common coexisting conditions and symptoms. Patterns of
autonomic dysfunction in IBS are not like the ones seen in fibromyalgia and chronic fatigue
syndrome, for example. And, fibromyalgia patients do not show the same gut pain sensitivity as
IBS patients, while conversely, IBS patients do not show the pain-sensitive tender points that are
characteristic of fibromyalgia(9-10). Furthermore, as can be seen from reviewing the symptom list in
Table 1, the non-GI symptoms that plague IBS patients are so varied and cover so many different
organ systems, that it would be hard to identify a specific biological connection between them. On
the contrary, it seems like the only overall commonality between these symptoms may be that they
are non-specific - they are, in other words, not clear symptoms of any identifiable disease processes
or diagnosable disorders. Indeed, the symptoms that are most common among IBS patients are
generally those that are also common in the general healthy population - they just tend to occur at a
higher level in people with IBS.
Statistical methods that estimate how much of the variability in one measured characteristic can be
explained by other measured factors tell us that the psychological symptoms roughly accounted for
25-30% of physical symptoms of these people. In short, psychological distress is almost certainly
part of the explanation for greater body symptoms in IBS, but not nearly the whole story.
Further research will have to determine which of the above explanations are applicable in IBS, but it
is likely that more than one of them, and maybe some other factors unrecognized so far, work
together to account for the high frequency of symptoms and disorders that co-exist with IBS.
It is by now well established that IBS patients visit doctors more than the general population. Only
recently has it been recognized, howver, that most of the extra health care visits that people with
IBS make are not for their bowel problems. Levy et al.(20) reported that IBS patients had about
twice as many doctor visits compared to other patients in the same HMO, but they found that 78%
of the additional visits were due to problems other than IBS. It seems quite likely that these extra
non-GI doctor visits of IBS patients are due to the tendency to experience more general body
symptoms over time, based on study results we presented at the Annual Meeting of the American
Gastroenterological Association last year(21). Using a scale asking patients about the 26 physical
symptoms in Table 1, we found that those IBS patients who report an unusually high number of
these symptoms over the past month missed six times as many days from school or work due to
illness compared to those with low or moderate (normal) symptoms. The "high-symptom" IBS
patients also had twice as many doctor visits and more hospital days, and their quality of life was
furthermore measurably poorer on the average. A general tendency to have a large number of body
symptoms is, therefore, very costly in terms of the IBS patient's overall wellbeing and ability to
function normally in life, and increases substantially the health care costs for these individuals.
These findings clearly underline the need to find a way to help the many IBS patients who score
unusually high on body symptom questionnaires to reduce that tendency.
Research in coming years will hopefully identify other ways to improve the well-being and life
functioning of IBS patients by reducing non-GI symptoms. This is likely to become an integral part
of managing IBS effectively in the subset of patients who suffer many symptoms and conditions
beyond the bowel.
References:
1. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27:37-40.
2. Jones KR, Palsson OS, Levy RL, Feld AJ, Longstreth GF, Bradshaw BH, Drossman DA, & Whitehead WE. Comorbid
disorders andsymptoms in irritable bowel syndrome (IBS) Compared to other gastroenterology patients. Gastroenterology
2001:120:A66.
3. Zaman MS, Chavez NF, Krueger R, Talley NJ, Lembo T. Extraintestinal symptoms in patients with irritable bowel syndrome
(IBS). Gastroenterology 2001; 120(Suppl 1):A636.
4. Maxton DG, Morris J, Whorwell PJ. More accurate diagnosis of irritable bowel syndrome by the use of "non-colonic"
symptomatology. Gut 1991; 32:784-786.
5. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other
disorders: what are the causes and implications? Gastroenterology 2002 Apr;
122(4):1140-56.
6. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia,
and temporomandibular disorder. Arch Intern Med 2000; 160: 221-227.
7. Walker EA, Gelfand AN, Gelfand MD, Green C, Katon WJ. Chronic pelvic pain and gynecological symptoms in women
with irritable bowel syndrome. J Psychosom Obstet Gynaecol 1996; 17:39-46.
8. Whitehead WE, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ. Excess comorbidity for somatic disorders in
irritable bowel syndrome (IBS) is related to hypervigilance.
Gastroenterology 2003 (abstract in press).
9. Chang L. The association of functional gastrointestinal disorders and fibromyalgia. Eur J Surg Suppl 1998 ;( 583):32-6.
10. Chang L, Mayer EA, Johnson T, FitzGerald LZ, Naliboff B. Differences in somatic perception in female patients with
irritable bowel syndrome with and without fibromyalgia. Pain 2000 Feb;
84(2-3):297-307.
11. Toner BB, Garfinkel PE, Jeejeebhoy KN. Psychological factors in irritable bowel syndrome. Can J Psychiatry. 1990 Mar;
35(2):158-61 12. Toner BB, Koyama E, Garfinkel PE, Jeejeebhoy KN, Di Gasbarro I. Social desirability and irritable bowel
syndrome. Int J Psychiatry Med 1992; 22(1):99-103.
12. Whitehead WE, Palsson OS, Jones KR, Turner MJ, Drossman DA. Role of parental modeling in somatization of adults with
irritable bowel syndrome. Gastroenterology 2000; 122 (Suppl 1):
A502.
13. Whitehead WE, Winget C, Fedoravicius AS, Wooley S, Blackwell B. Learned illness behavior in patients with irritable bowel
syndrome and peptic ulcer. Dig Dis Sci 1982 Mar;27(3):202-8.
14. Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and
pathological perception of visceral pain. Gastroenterology 1997 Jan;
112(1):64-72.
15. Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, Fournet J, Segebarth C. Central processing of rectal pain in
patients with irritable bowel syndrome: an fMRI study.Am J Gastroenterol 2002 Mar;97(3):654-61.
16. Bernstein CN, Frankenstein UN, Rawsthorne P, Pitz M, Summers R, McIntyre MC. Cortical mapping of visceral pain in
patients with GI disorders using functional magnetic resonance imaging. Am J Gastroenterol 2002 Feb;97(2):319-27.
17. Whitehead WE, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ. Comorbid psychiatric disorders in irritable bowel
syndrome (IBS) and inflammatory bowel disease (IBD).
Gastroenterology 2003 (abstract in press).
18. Palsson OS, Levy R,Von Korff M, Feld A, Turner MJ, Whitehead WE. Comorbidity and psychological distress in irritable
bowel syndrome (IBS). Gastroenterology 2003 (abstract in press).
19. Levy RL, Whitehead WE, Von Korff MR, Feld AD. Intergenerational transmission of gastrointestinal illness behavior. Am J
Gastroenterol 2000; 95:451-456.
20. Palsson, O.S., Jones K.R., Turner M.J., Drossman D.A., & Whitehead, W.E. (2002). Impact of somatization and comorbid
medical conditions on health care utilization, disability, and quality of life in irritable bowel syndrome (IBS).
Gastroenterology, 122 (Suppl 1): A501-502.
21. Palsson OS, Turner MJ, Johnson DA, Burnelt CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome:
investigation of mechanism and effects on symptoms. Dig Dis Sci 2002 Nov; 47(11):2605-14.
22. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical
service with examination of factors influencing responsiveness. Am J Gastroenterol 2002 Apr; 97(4):954-61.
23. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of
controlled clinical trials. Psychother Psychosom 2000 Jul-Aug; 69(4):205-15.